Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.3600
-0.0250-6.49%
Post-market: 0.37400.0140+3.89%16:59 EDT
Volume:2.14M
Turnover:800.92K
Market Cap:24.48M
PE:-0.47
High:0.3955
Open:0.3955
Low:0.3600
Close:0.3850
Loading ...

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
27 Jun

Reviva Pharmaceuticals Prices $10 Million Public Offering

MT Newswires Live
·
26 Jun

Reviva Pharmaceuticals prices 20M shares at 50c in public offering

TIPRANKS
·
26 Jun

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering

THOMSON REUTERS
·
26 Jun

Reviva Pharmaceuticals announces common stock, warrants offering

TIPRANKS
·
26 Jun

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

THOMSON REUTERS
·
26 Jun

Reviva Pharmaceuticals Appoints Baker Tilly as New Auditor Following Moss Adams Merger

Reuters
·
07 Jun

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
03 Jun

BRIEF-Reviva Announces Positive Full Dataset For 1-Year Phase 3 Recover Open Label Extension Study Evaluating Brilaroxazine In Schizophrenia

Reuters
·
02 Jun

Reviva Announces Positive Full Dataset for 1-Year Phase 3 Recover Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

THOMSON REUTERS
·
02 Jun

BRIEF-Reviva Pharmaceuticals Holdings Inc - Enters Into At Market Issuance Sales Agreement - SEC Filing

Reuters
·
31 May

Reviva Pharmaceuticals Holdings Inc - to Offer up to $50 Mln in Common Stock - SEC Filing

THOMSON REUTERS
·
31 May

Reviva Pharmaceuticals Launches $50 Million At-The-Market Stock Offering Through B. Riley Securities and Alliance Global Partners

Reuters
·
31 May

Analysts’ Top Healthcare Picks: Delcath Systems (DCTH), Reviva Pharmaceuticals Holdings (RVPH)

TIPRANKS
·
23 May

Reviva Pharmaceuticals price target lowered to $3 from $8 at D. Boral Capital

TIPRANKS
·
20 May

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
20 May

Roth MKM Sticks to Its Buy Rating for Reviva Pharmaceuticals Holdings (RVPH)

TIPRANKS
·
20 May

Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX) and Reviva Pharmaceuticals Holdings (RVPH)

TIPRANKS
·
18 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
16 May

Reviva Pharmaceuticals Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May